AL Amyloidosis Clinical Trials in Beijing
3 recruitingBeijing, China
Showing 1–3 of 3 trials
Recruiting
Phase 1
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
Relapsed/Refractory AL Amyloidosis
Gracell Biotechnologies (Shanghai) Co., Ltd.9 enrolled9 locationsNCT07250269
Recruiting
Phase 2
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
AL Amyloidosis
Peking Union Medical College Hospital35 enrolled1 locationNCT07079423
Recruiting
Not Applicable
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
AL Amyloidosis
Peking University People's Hospital20 enrolled2 locationsNCT06699394